Intuitive Surgical Inc diskutieren

Intuitive Surgical, Inc. (NASDAQ: ISRG) had its price target raised by analysts at Wells Fargo & Company from $363.00 to $416.00. They now have an "overweight" rating on the stock.

Intuitive Surgical, Inc. (NASDAQ: ISRG) had its price target raised by analysts at Piper Sandler from $325.00 to $425.00. They now have an "overweight" rating on the stock.

Intuitive Surgical, Inc. (NASDAQ: ISRG) had its price target raised by analysts at Stifel Nicolaus from $360.00 to $420.00. They now have a "buy" rating on the stock.

Intuitive Surgical, Inc. (NASDAQ: ISRG) had its price target raised by analysts at Truist Financial Co. from $390.00 to $435.00. They now have a "buy" rating on the stock.

Intuitive Surgical, Inc. (NASDAQ: ISRG) had its price target raised by analysts at Royal Bank of Canada from $400.00 to $432.00. They now have an "outperform" rating on the stock.

Intuitive Surgical, Inc. (NASDAQ: ISRG) had its price target raised by analysts at Raymond James from $372.00 to $435.00. They now have an "outperform" rating on the stock.

Intuitive Surgical, Inc. (NASDAQ: ISRG) had its price target raised by analysts at Barclays PLC from $385.00 to $430.00. They now have an "overweight" rating on the stock.

Intuitive Surgical, Inc. (NASDAQ: ISRG) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $420.00 price target on the stock.

Intuitive Surgical, Inc. (NASDAQ: ISRG) had its price target raised by analysts at Citigroup Inc. from $428.00 to $462.00. They now have a "buy" rating on the stock.

Intuitive Surgical, Inc. (NASDAQ: ISRG) had its price target raised by analysts at Stifel Nicolaus from $420.00 to $430.00. They now have a "buy" rating on the stock.

Intuitive Surgical, Inc. (NASDAQ: ISRG) had its price target raised by analysts at Piper Sandler from $425.00 to $435.00. They now have an "overweight" rating on the stock.

Intuitive Surgical, Inc. (NASDAQ: ISRG) had its price target raised by analysts at BTIG Research from $412.00 to $421.00. They now have a "buy" rating on the stock.

Intuitive Surgical is a cutting-edge medical technology company that has established itself as the market leader in robotic-assisted surgery. With its innovative da Vinci surgical system, Intuitive Surgical is revolutionizing the way complex procedures are performed, offering improved precision, reduced recovery times, and better outcomes for patients. The company's strong financial performance, impressive product pipeline, and positive industry trends suggest that Intuitive Surgical is well-positioned for continued growth. While the stock may experience some short-term volatility, the long-term outlook appears promising. As an investor, I'm bullish on Intuitive Surgical and believe it's a solid addition to a diversified portfolio.

Intuitive Surgical, Inc. (NASDAQ: ISRG) had its price target raised by analysts at Piper Sandler from $435.00 to $490.00. They now have an "overweight" rating on the stock.